Results 111 to 120 of about 26,198 (189)

Efficacy and safety of combined nebulization of unfractionated heparin, acetylcysteine, budesonide and ipratropium bromide in hospitalised patients with COVID-19 pneumonia: a randomized controlled clinical trial. [PDF]

BMC Pulm Med
Gong J, Nie N, Jiang M, Yang X, Wang Q, Deng J, Kang J, Li X, Zhang L, Zhang Y, Luo N, Du X, Wang L, Zhou W, Cao H, Li K, Cao G, Li L.   +17 more
europepmc   +1 more source

Heparin-Induced Hemorrhagic Bullous Dermatosis: A Rare Complication of Unfractionated Heparin. [PDF]

Cureus
Zakar R, Saad N, El Tannoury M, El Tannoury B, Ismail MA, Riachy M, Karam L.   +6 more
europepmc   +1 more source

Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points. [PDF]

TH Open
Gouin-Thibault I, Mansour A, Hardy M, Guéret P, de Maistre E, Siguret V, Cuker A, Mullier F, Lecompte T.   +8 more
europepmc   +1 more source

Systematic review of venous thromboembolism (VTE) occurrence in hospitalized patients receiving prophylactic unfractionated heparin twice vs. three times daily. [PDF]

J Thromb Thrombolysis
Flint SH, Woodruff AE, Maloney MK, Chilbert MR.   +3 more
europepmc   +1 more source

A comparison of anti-coagulation monitoring tests in ICU patients receiving a continuous infusion of unfractionated heparin. [PDF]

Crit Care Resusc
Spano S, Maeda A, Chaba A, Eastwood G, Randhawa M, Hogan C, Bellomo R, Warrillow S.   +7 more
europepmc   +1 more source

A Comparative Study Assessing the Incidence and Degree of Hyperkalemia in Patients on Unfractionated Heparin versus Low-Molecular Weight Heparin. [PDF]

Clin Pharmacol
Naseralallah L, Nasrallah D, Koraysh S, Aboelbaha S, Hussain TA.   +4 more
europepmc   +1 more source

Anti-factor Xa during unfractionated heparin therapy in critically ill patients: Development of prediction models using machine learning. [PDF]

Digit Health
Delange B, Bouzillé G, Guillot P, Bichon A, Bernard de Lajartre O, Gouin I, Launey Y, Mansour A, Lesouhaitier M, Tadié JM, Gacouin A, Cuggia M, Maamar A.   +12 more
europepmc   +1 more source

Evaluation of unfractionated heparin therapy for venous thromboembolism using adjusted body weight in elderly or higher weight patients. [PDF]

J Thromb Thrombolysis
Hopkins AJ, Chau T, Pullinger B, Kim S, Delic JJ, Igneri LA, Kim S.   +6 more
europepmc   +1 more source

Mortality and complications in low-dose vs standard-dose unfractionated heparin anticoagulation for extracorporeal membrane oxygenation: a systematic review and meta-analysis. [PDF]

Res Pract Thromb Haemost
Ng WW, Hui RW, Leung KC, Ng PY, Ngai CW, Sin SW, Sin CF.   +6 more
europepmc   +1 more source

Is an extended dose of subcutaneous nadroparin anticoagulation equally safe and feasible compared to unfractionated heparin anticoagulation during extracorporeal membrane oxygenation in critically ill COVID-19 patients? [PDF]

Anaesthesiol Intensive Ther
Piwowarczyk P, Szczukocka M, Uchacz A, Kutnik P, Czarnik T, Czuczwar M, Borys M.   +6 more
europepmc   +1 more source